Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Behind every perfect holiday memory is a mom on the brink - 2You finally got a doctor's appointment. Here's how to get the most out of it
- 3Bolsonaro discharged from hospital and placed under house arrest
- 4Starbucks' new 'Bearista' cup is causing a stir — and is being listed on eBay for $600
- 5Extraordinary Shows to Long distance race on a Plane
- Rights group: At least 2,500 deaths during protest crackdown in Iran
- Congolese rape survivors search in vain for medicine after USAID cuts
- Language Learning Stages: Which One Gets Your Vote?
- Esteem Stuffed Gaming Workstations to Consider
- ‘And then we saw the little head.’ Scientists witness rare sperm whale birth
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- 4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- Kids with smartphones by age 12 are at higher risk of health issues, study finds
- Asia's Noteworthy Destinations: A Voyager's Aide
